Standardized Hypertension Management to Reduce Cardiovascular Disease Morbidity and Mortality Worldwide

Authors: Pragna Patel, MD, MPH, Pedro Ordunez, MD, PhD, Kenneth Connell, MBBS, PhD, Dan Lackland, DrPH, Donald DiPette, MD


Cardiovascular diseases (CVDs) are the leading cause of death globally. In 2013, CVDs were responsible for approximately 17 million deaths worldwide (32%), with >75% occurring in low- and middle-income countries (LMICs).1

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. GBD 2013 Risk Factors Collaborators., Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks and clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287-2323.
2. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic review of population-based studies from 90 countries. Circulation 2016;134:441-450.
3. First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control. Prevention and control of NCDSL: priorities for investment. Moscow, 28-29 April 2011. Accessed June 1, 2016.
4. Nugent R. Benefits and costs of the non-communicable disease targets for the post-2015 development agenda. Published 2015. Accessed December 28, 2017.
5. Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA 2013;310:699-705.
6. McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011;183:1007-1013.
7. Harries AD, Zachariah R, Jahn A, et al. Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr 2009;52(Suppl 1):S14-S16.
8. Seita A, Harries AD. All we need to know in public health we can learn from tuberculosis care: lessons for non-communicable disease. Int J Tuberc Lung Dis 2013;17:429-430.
9. Frieden TR, Berwick DM. The “ Hearts” initiative-preventing heart attacks and strokes. N Engl J Med 2011;365:e27.
10. Jafar TH, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med 2009;151:593-601.
11. Patel P, Ordunez P, DiPette D, et al. Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich) 2016;18:1284-1294.
12. Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001;20:64-78.
13. PAHO TV. Standardized hypertension treatment project in Barbados. Accessed January 3, 2018.
14. Campbell NR, Lackland DT, Lisheng L, et al. The World Hypertension League challenges hypertension and cardiovascular organizations to develop strategic plans for the prevention and control of hypertension. J Clin Hypertens (Greenwich) 2015;17:325-327.
15. Angell SY, De Cock KM, Frieden TR. A public health approach to global management of hypertension. Lancet 2015;385:825-827.
16. World Health Organization. Global Hearts Initiative. Accessed November 28, 2016.